ALLERGAN INC·4

Jan 31, 6:54 PM ET

ALLERGAN INC 4

4 · ALLERGAN INC · Filed Jan 31, 2007

Insider Transaction Report

Form 4
Period: 2007-01-29
EVANS HANDEL
Director
Transactions
  • Award

    Phantom Stock Units

    2007-01-29$115.91/sh+8.63$1,00028,993.13 total
    Common Stock (0 underlying)
  • Award

    Phantom Stock Units

    2007-01-30$115.87/sh+17.26$2,00029,019.02 total
    Common Stock (0 underlying)
Footnotes (3)
  • [F1]Converts to common stock on a 1-for-1 basis.
  • [F2]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for meeting fees.
  • [F3]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. director.

Documents

1 file
  • 4
    eva566.xmlPrimary